Monday, October 26, 2026

Filings

Earlier SEC desk stories

T3 Defense Inc. Appoints New Chief Financial Officer

T3 Defense Inc. has appointed Shlomo Zakai as its new Chief Financial Officer, effective October 5, 2026, according to a recent SEC filing.

FatPipe Inc. Secures $6 Million in New Financing

FatPipe Inc. has filed an 8-K detailing a $6 million financing agreement with KeyBank, aimed at refinancing existing debt and improving cash flow.

Tessera Defense files 8-K on executive appointments and pay

Tessera Defense & Homeland Security Inc. files an 8-K detailing new compensation agreements for its CEO and CFO, impacting stockholder interests.

BANK5 2026-5YR24 Files 8-K with SEC on October 7, 2026

BANK5 2026-5YR24 submitted an 8-K filing detailing a new material agreement involving commercial mortgage pass-through certificates.

VIP Play, Inc. Files 8-K on Convertible Note Amendments

VIP Play, Inc. filed an 8-K detailing amendments to convertible notes, extending maturity dates and altering agreement terms, impacting investors.

Modine Manufacturing files amended 8-K following spin-off

Modine Manufacturing Co. has filed an amended 8-K to provide pro forma financial information after its recent spin-off of the Performance Technologies business.

Charlton Aria Acquisition Corp Files 8-K for Business Deal

Charlton Aria Acquisition Corp filed an 8-K with the SEC detailing a business combination with KQC Quantum, Inc. Read more about the implications.

FuelCell Energy announces executive transition plans

FuelCell Energy, Inc. files an 8-K detailing changes in executive leadership, including the departure of CFO Michael Bishop and the appointment of Matthew Latino.

Spyre Therapeutics Files 8-K for $350 Million Stock Offering

Spyre Therapeutics has filed an 8-K with the SEC for a $350 million public offering of common stock, which will fund its clinical programs.

Azenta Inc. Files 8-K on Restructuring and Impairment Charges

Azenta Inc. filed an 8-K detailing a restructuring plan that includes workforce reductions and site closures, impacting its Multiomics segment.

AIB Data Centers Inc. Files 8-K to Update Shareholders

AIB Data Centers Inc. filed an 8-K report detailing recent milestones and strategies for its CLT1 development, highlighting significant agreements and funding plans.

SRX Global Inc. Files Form 8-K for Major Acquisition Deal

SRX Global Inc. has filed an 8-K detailing a significant acquisition of CERo Therapeutics Holdings, impacting its future operations and financials.

American Fusion, Inc. Files 8-K with SEC on Key Changes

American Fusion, Inc. filed an 8-K detailing significant agreements, changes in accounting, and new preferred stock issuance. Here's what you need to know.

Federal Home Loan Bank of Des Moines Files Form 8-K

The Federal Home Loan Bank of Des Moines filed an 8-K with the SEC, detailing new financial obligations and their implications for the bank's operations.

WSFS Financial Corp Appoints New Executive Leadership Team

WSFS Financial Corp has announced executive appointments, including Michael Thompson as Interim Chief Accounting Officer, effective October 6, 2026.

Federal Home Loan Bank of Cincinnati Files Form 8-K

The Federal Home Loan Bank of Cincinnati filed an 8-K detailing its financial obligations and upcoming bond issuances, impacting investors and the housing market.

Picard Medical files Form 8-K for $1 million in notes

Picard Medical, Inc. files Form 8-K revealing $1 million in unsecured convertible notes. Details on interest rates and potential stock conversions included.

Ludwig Enterprises, Inc. Files Form 8-K on Accountant Change

Ludwig Enterprises, Inc. has filed a Form 8-K with the SEC announcing the resignation of its independent auditor, Stephano Slack LLC, effective June 22, 2026.

IT Tech Packaging, Inc. Changes Certifying Accountant

IT Tech Packaging, Inc. filed an 8-K with the SEC to announce the engagement of Audit Alliance LLP as its new independent accountant.

Bluejay Diagnostics Files 8-K on SYMON-II Clinical Study

Bluejay Diagnostics, Inc. filed an 8-K detailing the SYMON-II clinical study results, which may impact stakeholders in the medical diagnostics field.

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →